Categorize, Cluster & Classify - The 3C Strategy Applied to Alzheimer's Disease as a Case Study
暂无分享,去创建一个
Alexis Mitelpunkt | Mira Marcus-Kalish | Tal Galili | Netta Shachar | Yoav Benjamini | Y. Benjamini | T. Galili | Alexis Mitelpunkt | Netta Shachar | Mira Marcus-Kalish | Tal Galili
[1] C. Rowe,et al. Plasma apolipoprotein E and Alzheimer disease risk , 2011, Neurology.
[2] T. Montine,et al. Biomarkers for cognitive impairment and dementia in elderly people , 2008, The Lancet Neurology.
[3] J. Blass,et al. Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations , 2010 .
[4] et al.,et al. Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI) , 2009, NeuroImage.
[5] W. Revelle. psych: Procedures for Personality and Psychological Research , 2017 .
[6] Kirsti Malterud,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. the Nature of Clinical Knowledge the Art and Science of Clinical Knowledge: Evidence beyond Measures and Numbers Qualitative Research Series , 2022 .
[7] Robert Tibshirani,et al. Estimating the number of clusters in a data set via the gap statistic , 2000 .
[8] Daoqiang Zhang,et al. Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer's disease , 2012, NeuroImage.
[9] A. Dale,et al. Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimer Disease , 2010, American Journal of Neuroradiology.
[10] Andy Liaw,et al. Classification and Regression by randomForest , 2007 .
[11] Vikas Singh,et al. Predictive markers for AD in a multi-modality framework: An analysis of MCI progression in the ADNI population , 2011, NeuroImage.
[12] Mark E. Schmidt,et al. The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception , 2012, Alzheimer's & Dementia.
[13] Trey Sunderland,et al. Decreased-Amyloid 1-42 and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease , 2003 .
[14] C. Jack,et al. Boosting power for clinical trials using classifiers based on multiple biomarkers , 2010, Neurobiology of Aging.